Our Thinking

How big is the market for…?

We often are asked the size of the market for various segments of the bio/pharma contract services industry. In response, we’ve developed a resource page that addresses these questions. It includes sources, and in many cases we’ve added…

Trend Reports

CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance

Our research team crunched the numbers on 2014 drug approvals authorized by FDA’s CDER, CBER, Fast Track and Breakthrough drugs, and selected EMA approved drugs. The bottom line of this report is that…


Follow the Money: Viking Therapeutics, Inc.

Viking Therapeutics recently raised $24 million in the completion of an initial public offering.

The company contracts with Contract Research Organizations to…

Lead Sheet

Real-time Expert BD Intelligence

CROs, CMOs and CDMOs worldwide depend on the PharmSource Lead Sheet for fresh leads, up-to-date contact information and reliable market intelligence. Quickly scout well-targeted new business opportunities. Learn more

Strategic Advantage

Proprietary Global Sourcing Intelligence in an Instant

Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more

Market Intelligence

Serialization Requirements May Drive Pharmaceutical Companies to Re-examine Their CMO Use

Serialization will soon be a reality around the world, and the effort to comply with the complexity involved with compliance is likely to create winners and losers in the CMO industry.

Serialization, sometimes known as track-and-trace, refers to systems—usually country-specific—used to track…